| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |